SPANTRIA

Details for Australian Trade Mark No. 1054234 (hide)

Owner Lantheus Medical Imaging, Inc. a Delaware corporation

Service Spruson & Ferguson

Filing Date 6 May 2005

Classes

Class 5 Pharmaceutical preparations for the treatment and prevention of diabetes, incontinence, cardioivascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations, including antibiotics, antifungals and immunosuppressants; diagnostic imaging and ultrasound contrast agents; pharmaceutical preparations for diagnostic pharmaceutical products

Event Publications

26 May 2005 Application filed

8 September 2005 Application Accepted

12 January 2006 Trade Mark Registered/Protected

9 February 2006 Subsequent Owners/Holder Registered - Full Assignment

  Bristol-Myers Squibb Company a Delaware corporation is the full asignee of Bristol-Myers Squibb Medical Imaging, Inc. a Delaware corporation.

24 July 2008 Registrations/Protected IR Name Amendment and Changes

  The owner's/holder's name has been changed to Lantheus Medical Imaging, Inc. a Delaware corporation.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1054235-ABLAVAR

1054233-STEDIVAZE